No results for ‘’
Marksans Pharma Ltd
₹329.40
(0.30%)
Mon, 21 Sept 2026, 11:48 am
Health Technology
Pharmaceuticals: Major
24.5KMarksans Pharma Share Price Live Chart
1 Day
(0.30%)
No Result Found
Summary
Market Cap (in Cr)
11154.63
Net Profit (in Cr)
382.62
P/B
4.08
Sector P/E
33.76
P/E
26.47
EV/EBITDA
16.18
Debt/Equity (Industry)
0.26
Interest Cover (Industry)
10.81
ROCE (Industry)
16.40
RONW (Industry)
14.39
ROE
16.89
ROCE
20.19
Debt/Equity
0.12
EPS (TTM)
9.22
Dividend Yield
0
Book Value
66.71
Interest Cover
44.22
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 43.87 | 43.87 | 43.87 | 43.87 | 43.87 |
| FII | 16.76 | 8.12 | 16.92 | 19.88 | 22.20 |
| DII | 6.57 | 5.91 | 5.28 | 5.50 | 4.56 |
| Public | 32.79 | 42.09 | 33.93 | 30.75 | 29.37 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 481.95 | 395.30 | 358.45 | 308.65 | 271.80 | 222.00 | 135.35 |
| Fibonacci | 395.30 | 362.20 | 341.75 | 308.65 | 275.55 | 255.10 | 222.00 |
| Camarilla | 345.43 | 337.49 | 329.54 | 308.65 | 313.66 | 305.71 | 297.77 |
Pivots Level: Classic
R3
+173.30
481.95
R2
+86.65
395.30
R1
+49.80
358.45
S1
-36.85
271.80
S2
-86.65
222.00
S3
-173.30
135.35
Moving Average
Period
Value
10-EMA
325.75
20-EMA
322.35
30-EMA
316.14
50-EMA
302.48
100-EMA
274.13
200-EMA
245.34
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 26 May 2026 | board-meetings | Accounts, Quarterly Results, Dividend | |
| 05 Feb 2026 | board-meetings | Quarterly Results | |
| 13 Nov 2025 | board-meetings | Quarterly Results, Nine Months Results | |
| 11 Jul 2025 | agm | ||
| 01 Jul 2025 | dividend | Final Dividend - Rs. - 0.8 | 01 Aug 2025 |
| 19 May 2025 | dividend | ₹0.80 Dividend /Share | 01 Aug 2025 |
| 19 Aug 2024 | agm | ||
| 17 Aug 2024 | dividend | Final Dividend - Rs. - 0.6 | 17 Sept 2024 |
| 30 May 2024 | dividend | ₹0.60 Dividend /Share | 17 Sept 2024 |
| 02 Aug 2023 | agm |
Peer Comparison
Marksans Pharma Ltd
Cipla Ltd
Divis Laboratories Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Marksans Pharma Ltd About
Marksans Pharma is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. It operates two manufacturing facilities in Goa and maintains two R&D centers, one located in Goa and the other in Navi Mumbai.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1992
Headquarters
CEO
Mark Saldanha
Employees
Contact
Website
http://www.marksanspharma.com
companysecretary@marksanspharma.com ; info@marksan
Phone
91-22-40012000
Location
11th Flr GRANDEUR Oshiwara, Veera Desai Extn Rd Andheri(W), Mumbai, Maharashtra, 400053
Marksans Pharma Ltd Company History
| Year | History |
|---|---|
| 2017 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| UNIFI CAPITAL PRIVATE LIMITED | bulk | Buy | 7241309 | 231.5 | 28 Jul 2025 |
| SUBHKAM VENTURES I PRIVATE LIMITED | block | Buy | 537485 | 249.95 | 11 Jun 2025 |
| UNIFI BLEND FUND 2 | block | Buy | 3000000 | 249.95 | 11 Jun 2025 |
| UNIFI BCAD FUND | block | Buy | 560000 | 249.95 | 11 Jun 2025 |
| UNIFI CAPITAL PRIVATE LIMITED | block | Buy | 594000 | 249.95 | 11 Jun 2025 |
| ORBIMED ASIA IV MAURITIUS FVCI LIMITED | block | Sell | 10273443 | 249.95 | 11 Jun 2025 |
| CITIGROUP GLOBAL MARKETS SINGAPORE PTE LIMITED | block | Buy | 400081 | 249.95 | 11 Jun 2025 |
| UNIFI CAPITAL PRIVATE LIMITED -BLENDED RANGOLI | block | Buy | 3247600 | 249.95 | 11 Jun 2025 |
| SOCIETE GENERALE | block | Buy | 920184 | 249.95 | 11 Jun 2025 |
| ORBIMED ASIA IV MAURITIUS FVCI LIMITED | bulk | Sell | 10273443 | 249.95 | 11 Jun 2025 |
Frequently Asked Questions
1.What is the stock price of Marksans Pharma Ltd?
As of 21/09/2026 at 5:18 PM, Marksans Pharma Ltd shares are trading at ₹329.40.
2.What is the market cap. of Marksans Pharma Ltd?
As of 21/09/2026, the market capitalization of Marksans Pharma Ltd is ₹14,974.80 crore.
3.When was Marksans Pharma Ltd founded?
Marksans Pharma Ltd was founded in 1992.
4.What are the P/E and P/B ratios of Marksans Pharma Ltd?
As of 21/09/2026, Marksans Pharma Ltd has a P/E ratio of 28.89 and a P/B ratio of 4.08.
5.How can I buy shares of Marksans Pharma Ltd?
You can buy shares of Marksans Pharma Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Marksans Pharma Ltd?
As of March,2026, promoters hold 43.87% in Marksans Pharma Ltd, while FIIs, DIIs and public shareholders hold 16.76%, 6.57% and 32.79%, respectively.
7.Does Marksans Pharma Ltd pay dividends?
Yes, Marksans Pharma Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 0.8 per share.
8.What is the dividend yield of Marksans Pharma Ltd?
As of 21 September, 2026, the dividend yield of Marksans Pharma Ltd stands at 0.27%.
9.What are the latest financial results of Marksans Pharma Ltd?
For January,2024, Marksans Pharma Ltd reported revenue of ₹2,617.00 crore and a net profit of ₹381.00 crore.
10.What is the Stock symbol of Marksans Pharma Ltd?
MARKSANS is the stock symbol of Marksans Pharma Ltd.
11.Who is the CEO of Marksans Pharma Ltd?
The CEO of Marksans Pharma Ltd is Mark Saldanha.